$104 Million is the total value of Founders Fund VII Management, LLC's 2 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ABCL | ABCELLERA BIOLOGICS INC | $83,018,000 | -35.2% | 3,773,530 | 0.0% | 79.60% | -7.6% | |
CMPS | COMPASS PATHWAYS PLCsponsored ads | $21,279,000 | +3.6% | 557,760 | 0.0% | 20.40% | +47.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ABCELLERA BIOLOGICS INC | 12 | Q3 2023 | 94.5% |
COMPASS PATHWAYS PLC | 12 | Q3 2023 | 20.4% |
View Founders Fund VII Management, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Founders Fund VII Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.